Skip to main content

RainDance Signs JCVI as Early Access Partner for Sequence-Enrichment Technology

NEW YORK (GenomeWeb News) – RainDance Technologies said today that it has signed the J. Craig Venter Institute as an early-access partner for its microfluidics-based sequence-enrichment technology for next-generation sequencing.
 
Under the terms of the agreement, JCVI will have access to the company’s RDT 1000 instrument and Sequence Enrichment application, which are based on RainDance's RainStorm droplet-based technology platform.
 
The RDT 1000 generates picoliter-volume PCR reactions at a rate of 10 million reactions per hour, and the Sequence Enrichment application uses a library of PCR primers in droplets to amplify hundreds to thousands of genomic loci in a single tube, the company said.
 
Under the early-access agreement, RainDance said it is providing the RDT 1000 instrument, training, and customized PCR primer libraries designed to selectively amplify loci of interest for research initiatives at JCVI.
 
Robert Strausberg, deputy director and group leader in genomic medicine at JCVI, said in a statement that the institute’s scientists will use the RainDance technology in “various large-scale targeted sequencing studies.”
 
RainDance expects to launch the system commercially in the first quarter of 2009.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.